CONTACT SUPPORT
Online Inquiry
| Catalog: | GBAFP-CHEK2-01295 |
| Classification: | Gene-specific Break Apart Probes |
| Description: | Our Gene-specific Break Apart Probes usually target the flanks of the target gene (CHEK2). Due to this design method, our probe products can detect chromosomal rearrangements, such as translocations, by FISH.The product usually consists of a reagent combination composed of a probe with a selected dye color and a hybridization reagent. |
| Application: | CHEK2 Gene-specific Break Apart Probe is designed to detect potential CHEK2 rearrangements. This probe has been confirmed on the metaphase and interphase chromosomes by FISH. We provide a variety of dye color combinations for Break Apart Probes for customers to choose from. Probe products not only provide some classic color combinations, but also provide customized probe services. |
| Quantity: | 20 Tests |
| Probe Kits Volume (µL): | 40 μL |
| Hybridization Solution (µL): | 200 μL |
| Turnaround Time: | Within 10 Business Days |
| Shipping Time: | 1-2 Day Expedited Shipping |
| Shipping Conditions: | -20℃ |
| Storage Conditions: | Store at -20℃ and avoid light; |
| Gene Name | Checkpoint Kinase 2 |
| Gene Summary [Provided by RefSeq] | In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012] |
| Gene Symbol | CHEK2 |
| Location | 22q12.1 |
| Chromosome | Chromosome22 |
| Coordinates | This gene maps to 29083730-29137822 in GRCh37 coordinates. |
| Species | Human |
| Number | Dye Color | Order Name | Absorbance Maximum | Emission Maximum | Add to Cart |
| 1 | GR; OR | GBAFP-CHEK2-01295-GROR | 515nm;573nm | 491nm;548nm | |
| 2 | AQ; OR | GBAFP-CHEK2-01295-AQOR | 467nm;573nm | 418nm;548nm | |
| 3 | GO; GR | GBAFP-CHEK2-01295-GOGR | 551nm;515nm | 525nm;491nm | |
| 4 | GO; RE | GBAFP-CHEK2-01295-GORE | 551nm;599nm | 525nm;580nm | |
| 5 | GR; GO | GBAFP-CHEK2-01295-GRGO | 515nm;551nm | 491nm;525nm | |
| 6 | GR; RE | GBAFP-CHEK2-01295-GRRE | 515nm;599nm | 491nm;580nm | |
| 7 | OR; GR | GBAFP-CHEK2-01295-ORGR | 573nm;515nm | 548nm;491nm | |
| 8 | RE; GO | GBAFP-CHEK2-01295-REGO | 599nm;551nm | 580nm;525nm | |
| 9 | RE; GR | GBAFP-CHEK2-01295-REGR | 599nm;515nm | 580nm;491nm |
Other Products